Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases in a bid to improve the access to treatments, which are few and far between. While 27 medicines to address ...

Subscribe for weekly updates featuring: Listicles on the most promising biotechs Deep dives into emerging technologies Key insights into industry trends The week’s biggest biotech funding rounds ...

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

The longevity biotech industry revolves around the goal of increasing the period of life that a person spends in good health. There has been a rapidly expanding effort in recent years to develop drugs ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Cambridge Symposium: Novel Approaches in Translational Oncology – 26th March, 2026 Join industry and academic leaders in Cambridge for Champions Oncology’s UK Symposium, a one‑day, in‑person event ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...